share_log

4: Statement of changes in beneficial ownership of securities-Director Harrington-Smith Kristen

4: Statement of changes in beneficial ownership of securities-Director Harrington-Smith Kristen

4:持股变动声明-董事 Harrington-Smith Kristen
美股SEC公告 ·  06/13 18:24

Moomoo AI 已提取核心信息

In a recent transaction, Kristen Harrington-Smith, associated with eFFECTOR Therapeutics, Inc. (EFTR), executed a stock transaction on June 13, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the post-transaction shareholding were not disclosed. This financial activity pertains directly to eFFECTOR Therapeutics, a company trading under the symbol EFTR on the stock market.
In a recent transaction, Kristen Harrington-Smith, associated with eFFECTOR Therapeutics, Inc. (EFTR), executed a stock transaction on June 13, 2024. The specific details regarding the nature of the shares, the number of shares transacted, the transaction price, and the post-transaction shareholding were not disclosed. This financial activity pertains directly to eFFECTOR Therapeutics, a company trading under the symbol EFTR on the stock market.
近期,与eFFECTOR Therapeutics, Inc. (EFTR)相关人员Kristen Harrington-Smith于2024年6月13日进行了一笔股票交易。关于股票的性质、交易数量、交易价格和交易后的持股情况等具体细节未披露。这项金融活动直接涉及eFFECTOR Therapeutics这家在股票市场上以EFTR为标的进行交易的公司。
近期,与eFFECTOR Therapeutics, Inc. (EFTR)相关人员Kristen Harrington-Smith于2024年6月13日进行了一笔股票交易。关于股票的性质、交易数量、交易价格和交易后的持股情况等具体细节未披露。这项金融活动直接涉及eFFECTOR Therapeutics这家在股票市场上以EFTR为标的进行交易的公司。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息